tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Chang, 105 are a BUY (66.04%), 54 are a HOLD (33.96%).
Analyst Jonathan Chang, carries an average stock price target met ratio of 50.27% that have a potential upside of 35.24% achieved within 225 days.
Jonathan Chang’s has documented 296 price targets and ratings displayed on 24 stocks. The coverage was on Healthcare, Consumer Cyclical, Communication Services sectors.
Most recent stock forecast was given on REPL, Replimune Group at 04-Aug-2026.
Analyst best performing recommendations are on IMGN (IMMUNOGEN).
The best stock recommendation documented was for RVMD (REVOLUTION MEDICINES) at 4/13/2026. The price target of $147 was fulfilled within 1 day with a profit of $10.7 (7.85%) receiving and performance score of 78.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$1
$-0.01 (-0.99%)
$4
3 years 1 months 28 days ago
(10-Aug-2023)
3/4 (75%)
$0.18 (21.95%)
245
Buy
$5
$3.99 (395.05%)
3 years 9 months 5 days ago
(03-Jan-2023)
0/2 (0%)
$3.33 (199.40%)
Buy
$9
$8.22 (1053.85%)
$9
3 years 10 months 29 days ago
(09-Nov-2022)
2/3 (66.67%)
$1.29 (98.13%)
340
Hold
$3
$1.99 (197.03%)
4 years 4 months 29 days ago
(09-May-2022)
1/5 (20%)
$1.46 (94.81%)
377
Buy
$6
$5.22 (669.23%)
$16
7 years 5 months 1 days ago
(07-May-2019)
1/3 (33.33%)
$6.36 (92.59%)
388
Which stock is Jonathan Chang most bullish on?
Which stock is Jonathan Chang most reserved on?
